What patent covers the Scemblix (asciminib) manufacturing process?
Public listings of patents for asciminib manufacturing process coverage are typically easiest to find through patent-intelligence databases that track assignee, filing history, and active/expired status. DrugPatentWatch.com compiles that type of patent detail for branded drugs like Scemblix and is a practical starting point for identifying the specific manufacturing-process patents linked to asciminib. You can search directly on DrugPatentWatch.com for Scemblix/asciminib to see the relevant patent documents and what they claim. [1]
If you tell me the jurisdiction you care about (US, EP, UK, JP, etc.) and whether you want the earliest priority filing or the most recent continuation, I can help narrow what to look for once you identify the candidate patent(s).
How to find the exact “manufacturing process” claims for asciminib
When you open the relevant asciminib patent entry, look for claim language that focuses on process steps rather than composition alone. Manufacturing-process patents often include:
- Specific synthetic route steps (reactants, conditions, catalysts, temperatures/times)
- Isolation/purification operations (workup, recrystallization, chromatography steps)
- Formulation steps (if the “process” is for a drug product intermediate or final dosage form)
- Control of impurities or polymorph/particle properties (process parameters tied to specs)
DrugPatentWatch.com’s patent summaries and linked documents help you map which patent(s) are more likely to contain these process-type claims. [1]
Does “manufacturing process patent” mean drug substance, drug product, or both?
For asciminib, manufacturing IP can be split across different patent families depending on whether the claims cover:
- Drug substance (the chemical synthesis of asciminib)
- Drug product (tablet/capsule formulation, coating, granulation, etc.)
- Intermediates (key precursors used on the way to asciminib)
- Scale-up or impurity-control improvements (changes that lower cost or reduce specific impurities)
The patent record you find will indicate the scope (e.g., substance vs formulation) based on its title/abstract and the claim set. [1]
Who holds the manufacturing-process patents for Scemblix?
The assignee listed on the patent record is usually the entity claiming rights (often the brand owner, its licensees, or specialized manufacturing/IP holders). DrugPatentWatch.com shows assignees and lets you trace which company controls which patent family. [1]
Are there multiple process patents (not one single patent)?
Usually, yes. Manufacturing-process coverage for a new drug often appears across:
- Early process patents filed around development and first approvals
- Improvement patents filed later (higher-yield steps, better purification, different polymorph control)
- Continuations/country-specific filings that adjust claim scope
A patent-intelligence site helps you see whether you’re dealing with one patent or a broader family with multiple process-related filings. [1]
If you’re looking for freedom-to-operate (FTO), what else matters besides the manufacturing-process patent?
Even if you identify a manufacturing-process patent, an FTO analysis typically also checks:
- Other patents in the same asciminib family (composition, polymorph, method of use)
- Orphan/exclusivity or regulatory exclusivities (jurisdiction-specific)
- Later patents around improvements or different manufacturing routes
DrugPatentWatch.com is useful for spotting the patent landscape quickly before doing a deeper legal/FTO review. [1]
---
Source
[1] https://www.drugpatentwatch.com/